Shopping Cart
- Remove All
- Your shopping cart is currently empty
Val-Cit-PABC-DOX (compound 10109), a conjugate based on epsilon-poly-L-lysine, functions as an agent-linker for ADC, employing Doxorubicin—an inhibitor of both DNA topoisomerase I and II—as the linked agent via the Val-Cit-PABC linker.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Val-Cit-PABC-DOX (compound 10109), a conjugate based on epsilon-poly-L-lysine, functions as an agent-linker for ADC, employing Doxorubicin—an inhibitor of both DNA topoisomerase I and II—as the linked agent via the Val-Cit-PABC linker. |
Molecular Weight | 948.97 |
Formula | C46H56N6O16 |
Cas No. | 1022094-34-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.